Advertisement
Screener

PAVmed Inc. (PAVM) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

PAVmed Inc. Operating Cash Flow

PAVmed Inc. (PAVM) reported Operating Cash Flow of -$5.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13

  • PAVmed Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.66M.
  • PAVmed Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.62M.
  • PAVmed Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.55M, a 1750.00% decline year-over-year.
  • PAVmed Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$896.00K.
  • PAVmed Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$5.21M.
  • PAVmed Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$33.55M.
  • PAVmed Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$52.04M.
  • PAVmed Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$70.98M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$2.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$5.28M
10-Q · filed 2026-08-13
-$6.83M
derived: sum of 3 quarters · filed 2026-08-13
-$7.73M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$2.62M
10-Q · filed 2026-05-14
-$4.17M
derived: sum of 2 quarters · filed 2026-05-14
-$5.07M
derived: sum of 3 quarters · filed 2026-05-14
-$6.25M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$1.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$2.45M
derived: sum of 2 quarters · filed 2026-03-27
-$3.63M
derived: sum of 3 quarters · filed 2026-08-13
-$5.21M
10-K · filed 2026-03-27
2025-09-30-$896.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$2.07M
derived: sum of 2 quarters · filed 2026-08-13
-$3.65M
10-Q · filed 2025-11-12
-$3.56M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$1.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$2.76M
10-Q · filed 2026-08-13
-$2.67M
derived: sum of 3 quarters · filed 2026-08-13
-$11.55M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$1.58M
10-Q · filed 2026-05-14
-$1.49M
derived: sum of 2 quarters · filed 2026-05-14
-$10.37M
derived: sum of 3 quarters · filed 2026-05-14
-$22.03M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$94.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$8.79M
derived: sum of 2 quarters · filed 2026-03-27
-$20.45M
derived: sum of 3 quarters · filed 2026-03-27
-$33.55M
10-K · filed 2026-03-27
2024-09-30-$8.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$20.54M
derived: sum of 2 quarters · filed 2025-11-12
-$33.65M
10-Q · filed 2025-11-12
-$45.52M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$11.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$24.77M
10-Q · filed 2025-08-14
-$36.64M
derived: sum of 3 quarters · filed 2025-08-14
-$47.73M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$13.11M
10-Q · filed 2025-05-15
-$24.98M
derived: sum of 2 quarters · filed 2025-05-15
-$36.07M
derived: sum of 3 quarters · filed 2025-05-15
-$48.78M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$11.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
-$22.96M
derived: sum of 2 quarters · filed 2025-03-24
-$35.67M
derived: sum of 3 quarters · filed 2025-03-24
-$52.04M
10-K · filed 2025-03-24
2023-09-30-$11.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$23.80M
derived: sum of 2 quarters · filed 2024-11-14
-$40.16M
10-Q · filed 2024-11-14
-$56.98M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$12.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$29.07M
10-Q · filed 2024-08-12
-$45.90M
derived: sum of 3 quarters · filed 2024-08-12
-$65.24M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$16.36M
10-Q · filed 2024-05-13
-$16.29M
10-Q · filed 2023-05-15
-$33.19M
derived: sum of 2 quarters · filed 2024-05-13
-$52.53M
derived: sum of 3 quarters · filed 2024-05-13
-$75.08M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$16.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$36.16M
derived: sum of 2 quarters · filed 2024-03-25
-$58.72M
derived: sum of 3 quarters · filed 2024-03-25
-$70.98M
10-K · filed 2024-03-25
2022-09-30-$19.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$41.90M
derived: sum of 2 quarters · filed 2023-11-13
-$54.16M
10-Q · filed 2023-11-13
-$70.94M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$22.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$34.82M
10-Q · filed 2023-08-14
-$51.60M
derived: sum of 3 quarters · filed 2023-08-14
-$59.62M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$12.26M
10-Q · filed 2023-05-15
-$29.04M
derived: sum of 2 quarters · filed 2023-05-15
-$37.06M
derived: sum of 3 quarters · filed 2023-05-15
-$43.69M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$16.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
-$24.80M
derived: sum of 2 quarters · filed 2023-03-14
-$31.42M
derived: sum of 3 quarters · filed 2023-03-14
-$40.59M
10-K · filed 2023-03-14
2021-09-30-$8.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$14.65M
derived: sum of 2 quarters · filed 2022-11-14
-$23.81M
10-Q · filed 2022-11-14
-$30.54M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$6.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$15.80M
10-Q · filed 2022-08-15
-$22.52M
derived: sum of 3 quarters · filed 2022-08-15
-$28.36M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$9.17M
10-Q · filed 2022-05-16
-$15.90M
derived: sum of 2 quarters · filed 2022-05-16
-$21.74M
derived: sum of 3 quarters · filed 2022-05-16
-$27.29M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$6.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06
-$12.57M
derived: sum of 2 quarters · filed 2022-04-06
-$18.12M
derived: sum of 3 quarters · filed 2022-04-06
-$21.91M
10-K · filed 2022-04-06
2020-09-30-$5.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22
-$11.39M
derived: sum of 2 quarters · filed 2021-11-22
-$15.19M
10-Q · filed 2021-11-22
-$19.28M
derived: sum of 4 quarters · filed 2021-11-22
2020-06-30-$5.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$9.35M
10-Q · filed 2021-08-16
-$13.44M
derived: sum of 3 quarters · filed 2021-08-16
-$16.31M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$3.79M
10-Q · filed 2021-05-17
-$7.88M
derived: sum of 2 quarters · filed 2021-05-17
-$10.76M
derived: sum of 3 quarters · filed 2021-05-17
-$13.28M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$4.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$6.97M
derived: sum of 2 quarters · filed 2021-03-15
-$9.49M
derived: sum of 3 quarters · filed 2021-03-15
-$13.36M
10-K · filed 2021-03-15
-$13.36M
10-K · filed 2020-04-14
2019-09-30-$2.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$5.40M
derived: sum of 2 quarters · filed 2020-11-06
-$9.27M
10-Q · filed 2020-11-06
-$9.27M
10-Q · filed 2019-11-19
-$12.29M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$2.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
-$6.39M
10-Q · filed 2020-08-14
-$6.39M
10-Q · filed 2019-08-14
-$9.41M
derived: sum of 3 quarters · filed 2020-08-14
-$11.27M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$3.87M
10-Q · filed 2020-05-28
-$3.87M
10-Q · filed 2019-05-15
-$6.89M
derived: sum of 2 quarters · filed 2020-05-28
-$8.76M
derived: sum of 3 quarters · filed 2020-05-28
-$10.46M
derived: sum of 4 quarters · filed 2020-05-28
2018-12-31-$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14
-$4.89M
derived: sum of 2 quarters · filed 2020-04-14
-$6.59M
derived: sum of 3 quarters · filed 2020-04-14
-$8.79M
10-K · filed 2020-04-14
2018-09-30-$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19
-$3.57M
derived: sum of 2 quarters · filed 2019-11-19
-$5.77M
10-Q · filed 2019-11-19
-$7.36M
derived: sum of 4 quarters · filed 2019-11-19
2018-06-30-$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$3.90M
10-Q · filed 2019-08-14
-$5.49M
derived: sum of 3 quarters · filed 2019-08-14
-$7.86M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$2.20M
10-Q · filed 2019-05-15
-$3.79M
derived: sum of 2 quarters · filed 2019-05-15
-$6.16M
derived: sum of 3 quarters · filed 2019-05-15
2017-12-31-$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$3.96M
derived: sum of 2 quarters · filed 2019-04-01
-$6.61M
10-K · filed 2019-04-01
2017-09-30-$2.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$5.02M
10-Q · filed 2018-11-14
2017-06-30-$2.65M
10-Q · filed 2018-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14